Pi Insight
Pi Foresight
FTO and Infringement Risk
Strategic Reports
Webinars
Your experience on this site will be improved by allowing cookies.
Revolutionizing Medicine: Antibody-Drug Conjugates (ADCs)
Sep, 2025
ADCs Driving Oncology Innovation Antibody-drug conjugates (ADCs) are transforming cancer treatment. This report highlights market growth, 76 ADCs in development, licensing trends, MENA gaps, and China’s growing influence.
